Ladarixin sodium (DF 2156A) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist. Ladarixin sodium can be used for the research of COPD and asthma[1].
Molecular Weight:
397.32
Purity:
99.84
CAS Number:
[865625-56-5]
Formula:
C11H11F3NNaO6S2
Target:
CXCR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted